Full Access with Signal8 Pro, $49/mo billed annually.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Healthcare Information Services
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 27.30M shares outstanding
Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies.
Its product includes aprevo, a medical platform that makes surgical plans and devices tailored to the precise medical situation of every individual patient.
It provides New Technology Add-On Payment (NTAP) reimbursement.
The company was incorporated in 2018 and is based in Carlsbad, California.
Jonathan (Jon) D. Root, M.D., M.B.A.
Director
Kevin O’Boyle
Director
Kevin Sidow
Director
Michael (Mike) Cordonnier
Chairman, Chief Executive Officer, President & Co-Founder
Employees
100
Country
US
Sector
Healthcare
Website
carlsmed.com
Loading congressional disclosures…
based on 27.30M shares outstanding
30d Avg
85.86K
60d Avg
114.19K
90d Avg
124.04K